BGM
MBX

Burkehill Global Management’s MBX Biosciences MBX Stock Holding History

Burkehill Global Management’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.98M Hold
100,000
– – 0.15% 104
2025
Q4 		$3.15M Hold
100,000
– – 0.21% 96
2025
Q3 		$1.75M Buy
+100,000
New +$1.34M 0.1% 124

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Burkehill Global Management's MBX Position: Q1 2026 in Review

Burkehill Global Management held its MBX Biosciences (MBX) position steady in Q1 2026 at 100,000 shares worth $2.98M. The position accounts for 0.15% of the portfolio, ranked #104.

Burkehill Global Management first reported a position in MBX in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.15M in Q4 2025. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • Burkehill Global Management held 100,000 shares of MBX Biosciences worth $2.98M as of Q1 2026.
  • Burkehill Global Management left its MBX Biosciences share count unchanged in Q1 2026.
  • MBX Biosciences made up 0.15% of Burkehill Global Management's portfolio in Q1 2026, its #104 holding.
  • Burkehill Global Management first reported a position in MBX Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Burkehill Global Management's MBX Biosciences position peaked at $3.15M in Q4 2025.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on Burkehill Global Management's 13F filing for Q1 2026, filed 15 May 2026.